Imunon, Inc. Fair Value Adjustment of Warrants
Imunon, Inc. (IMNN) reported Fair Value Adjustment of Warrants of $61.25 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-24.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2017-03-24
- Imunon, Inc. fair value adjustment of warrants for the quarter ending 2015-12-31 was $0.00.
- Imunon, Inc. fair value adjustment of warrants for the quarter ending 2015-09-30 was $0.00.
- Imunon, Inc. fair value adjustment of warrants for the quarter ending 2015-06-30 was $18.02K, a 3.20% decline year-over-year.
- Imunon, Inc. fair value adjustment of warrants for the quarter ending 2015-03-31 was $43.23K.
- Imunon, Inc. fair value adjustment of warrants for fiscal 2015 was $61.25K.
- Imunon, Inc. fair value adjustment of warrants for fiscal 2014 was -$204.28K.
- Imunon, Inc. fair value adjustment of warrants for fiscal 2013 was -$8.09M, a 296.49% decline from fiscal 2012.
- Imunon, Inc. fair value adjustment of warrants for fiscal 2012 was $4.12M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $0.00 derived: sum of 2 quarters · filed 2017-03-24 | $18.02K derived: sum of 3 quarters · filed 2017-03-24 | $61.25K 10-K · filed 2017-03-24 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $18.02K derived: sum of 2 quarters · filed 2016-11-10 | $61.25K 10-Q · filed 2016-11-10 | -$61.79K derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $18.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $61.25K 10-Q · filed 2016-08-15 | -$61.79K derived: sum of 3 quarters · filed 2016-08-15 | -$158.62K derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | $43.23K 10-Q · filed 2016-05-16 | -$79.81K derived: sum of 2 quarters · filed 2016-05-16 | -$176.64K derived: sum of 3 quarters · filed 2016-05-16 | -$158.03K derived: sum of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | -$123.04K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$219.87K derived: sum of 2 quarters · filed 2016-03-30 | -$201.25K derived: sum of 3 quarters · filed 2016-03-30 | -$204.28K 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$96.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$78.22K derived: sum of 2 quarters · filed 2015-11-05 | -$81.24K 10-Q · filed 2015-11-05 | -$30.30K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-06-30 | $18.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $15.59K 10-Q · filed 2015-08-10 | $476.26K 10-Q · filed 2014-08-07 | $66.53K derived: sum of 3 quarters · filed 2016-03-30 | |
| 2014-03-31 | -$3.03K 10-Q · filed 2015-05-11 | $47.91K derived: sum of 2 quarters · filed 2016-03-30 | |||
| 2013-12-31 | $50.94K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$8.09M 10-K · filed 2016-03-30 | |||
| 2013-09-30 | -$8.14M 10-Q · filed 2014-11-10 | ||||
| 2012-12-31 | $4.12M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |